Skip to main content
GDRX logo

GDRX · GoodRx Holdings, Inc. · Webcasts, Transcripts & Audio

Track GDRX — free
$3.36 -0.11 (-3.17%) At close · Nov 18 Play latest call Q2 2026 earnings call transcript
Market Cap
$1.15B
Shares
341.15M
Volume · Nov 18 659.27K Avg daily vol (3M) 1.14M

GoodRx Holdings, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for GoodRx Holdings, Inc. (GDRX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q2
2026-08-06
GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript
Confident tone GLP-1 access and demand PharmaDirect growth CFO transition
Revenue
$200.41M
▼ 1.3% YoY
Diluted EPS
$0.02
▼ 50% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript
Positive tone TrumpRx integration and incremental volume Subscription and weight loss offering PharmaDirect growth and scale
Revenue
$194.01M
▼ 4.4% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
GoodRx Holdings, Inc. (GDRX) Q4 2025 Earnings Call Transcript
Confident tone Pharma Manufacturer Solutions / Pharma Direct Consumer Reach and Engagement Subscriptions
Revenue
$194.78M*
▼ 1.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
GoodRx Holdings, Inc. (GDRX) Q3 2025 Earnings Call Transcript
Positive tone Pharma Manufacturer Solutions growth Policy environment / TrumpRx & MFN Kroger RxSmartSaver / retail partnerships
Revenue
$196.03M
▲ 0.4% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
GoodRx Holdings, Inc. (GDRX) Q2 2025 Earnings Call Transcript
Positive tone Integrated Savings Program (ISP) headwinds Pharma manufacturer solutions growth Retail and prescription marketplace partnerships
Revenue
$203.07M
▲ 1.2% YoY
Diluted EPS
$0.04
▲ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
GoodRx Holdings, Inc. (GDRX) Q1 2025 Earnings Call Transcript
Positive tone Prescription marketplace and pharmacy partnerships Rite Aid bankruptcy Pharma Manufacturer Solutions and GLP-1 opportunity
Revenue
$202.97M
▲ 2.6% YoY
Diluted EPS
$0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
GoodRx Holdings, Inc. (GDRX) Q4 2024 Earnings Call Transcript
Confident tone Healthcare professional workflow tools and technology Integrated Savings Program (ISP) and direct contracting Pharmacy partnerships and cost-plus economics
Revenue
$198.58M*
▲ 1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript
Positive tone Integrated Savings Program (ISP) Pharma manufacturer solutions / brand growth Adjusted EBITDA performance
Revenue
$195.25M
▲ 8.5% YoY
Diluted EPS
$0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
GoodRx Holdings, Inc. (GDRX) Q2 2024 Earnings Call Transcript
Cautious tone Retail pharmacy store closures Integrated Savings Program (ISP) Pharma manufacturer solutions
Revenue
$200.61M
▲ 5.8% YoY
Diluted EPS
$0.02
▼ 85.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
GoodRx Holdings, Inc. (GDRX) Q1 2024 Earnings Call Transcript
Positive tone Integrated Savings Program (ISP) Pharma Manufacturer Solutions Retail direct contracting shift
Revenue
$197.88M
▲ 7.6% YoY
Diluted EPS
$0.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
GoodRx Holdings, Inc. (GDRX) Q4 2023 Earnings Call Transcript
Positive tone Retail pharmacy partnerships / hybrid model Integrated savings program (ISP) for commercial plans 2024 financial outlook
Revenue
$196.64M*
▲ 6.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
GoodRx Holdings, Inc. (GDRX) Q3 2023 Earnings Call Transcript
Revenue
$179.96M
▼ 3.9% YoY
Diluted EPS
$-0.09
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
GoodRx Holdings, Inc. (GDRX) Q2 2023 Earnings Call Transcript
Revenue
$189.68M
▼ 1.1% YoY
Diluted EPS
$0.14
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-25
GoodRx Holdings, Inc. (GDRX) Q1 2023 Earnings Call Transcript
Revenue
$183.99M
▼ 9.5% YoY
Diluted EPS
$-0.01
▼ 133.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
GoodRx Holdings, Inc. (GDRX) Q4 2022 Earnings Call Transcript
Revenue
$184.11M*
▼ 13.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
GoodRx Holdings, Inc. (GDRX) Q3 2022 Earnings Call Transcript
Revenue
$187.32M
▼ 4% YoY
Diluted EPS
$-0.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
GoodRx Holdings, Inc. (GDRX) Q2 2022 Earnings Call Transcript
Revenue
$191.80M
▲ 8.6% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
GoodRx Holdings, Inc. (GDRX) Q1 2022 Earnings Call Transcript
Revenue
$203.33M
▲ 26.7% YoY
Diluted EPS
$0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-28
GoodRx Holdings, Inc. (GDRX) Q4 2021 Earnings Call Transcript
Revenue
$213.26M*
▲ 38.9% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
GoodRx Holdings, Inc. (GDRX) Q3 2021 Earnings Call Transcript
Revenue
$195.10M
▲ 38.9% YoY
Diluted EPS
$-0.04
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
GoodRx Holdings, Inc. (GDRX) Q2 2021 Earnings Call Transcript
Revenue
$176.63M
▲ 43.3% YoY
Diluted EPS
$0.07
▼ 12.5% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
GoodRx Holdings, Inc. (GDRX) Q1 2021 Earnings Call Transcript
Revenue
$160.43M
▲ 20.3% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-11
GoodRx Holdings, Inc. (GDRX) Q4 2020 Earnings Call
Revenue
$153.54M*
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
GoodRx Holdings, Inc. (GDRX) Q3 2020 Earnings Call Transcript
Revenue
$140.45M
▲ 38% YoY
Diluted EPS
$-0.21
▼ 520% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–24 of 24 webcasts
Key facts CIK 1809519 CUSIP 38246G108 13F (30d) 191 filings 174 filers Visit website Investor relations